<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" bill-type="olc" dms-id="A1" public-print="no" public-private="public" stage-count="1" star-print="no-star-print"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 S648 IS: Medicare Formulary Improvement Act of 2015</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2015-03-04</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form display="yes">
<distribution-code display="yes">II</distribution-code><congress display="yes">114th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">S. 648</legis-num><current-chamber display="yes">IN THE SENATE OF THE UNITED STATES</current-chamber><action display="yes"><action-date date="20150304">March 4, 2015</action-date><action-desc><sponsor name-id="S153">Mr. Grassley</sponsor> (for himself and <cosponsor name-id="S307">Mr. Brown</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSFI00">Committee on Finance</committee-name></action-desc></action><legis-type display="yes">A BILL</legis-type><official-title display="yes">To amend title XVIII of the Social Security Act to improve formulary requirements for prescription
			 drug plans and MA–PD plans with respect to certain categories or classes
 of drugs.</official-title></form><legis-body display-enacting-clause="yes-display-enacting-clause" style="OLC"><section commented="no" display-inline="no-display-inline" id="S1" section-type="section-one"><enum>1.</enum><header display-inline="yes-display-inline">Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Medicare Formulary Improvement Act of 2015</short-title></quote>.</text></section><section commented="no" display-inline="no-display-inline" id="id5573e8feb5324f1c91ee7d119e4110d6" section-type="subsequent-section"><enum>2.</enum><header display-inline="yes-display-inline">Improving formulary requirements for prescription drug plans and MA–PD plans with respect to
 certain categories or classes of drugs</header><subsection commented="no" display-inline="no-display-inline" id="id2a67e20a69044aab853c2d2411ad533c"><enum>(a)</enum><header display-inline="yes-display-inline">In general</header><text display-inline="yes-display-inline">Section 1860D–4(b)(3)(G) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-104">42 U.S.C. 1395w–104(b)(3)(G)</external-xref>) is amended to read as follows:</text><quoted-block display-inline="no-display-inline" id="idae1b9ec65a224a7e987036fd7544a74d" style="OLC"><subparagraph commented="no" display-inline="no-display-inline" id="idc9a4d8d0bf9146608e2a46c1e0efae19"><enum>(G)</enum><header display-inline="yes-display-inline">Required inclusion of drugs in certain categories and classes</header><clause commented="no" display-inline="no-display-inline" id="id868abb8ff30d4450a746fc6787306096"><enum>(i)</enum><header display-inline="yes-display-inline">Formulary requirements</header><subclause commented="no" display-inline="no-display-inline" id="id1cb9da03e48f45f5bd1e58c423a0ac41"><enum>(I)</enum><header display-inline="yes-display-inline">In general</header><text display-inline="yes-display-inline">Subject to subclause (II), a PDP sponsor offering a prescription drug plan shall be required to include all covered part D drugs in the categories and classes described in clause (iii).</text></subclause><subclause commented="no" display-inline="no-display-inline" id="id28bc41f369474b11aa9962e9c85f74af"><enum>(II)</enum><header display-inline="yes-display-inline">Exceptions</header><text display-inline="yes-display-inline">Subject to clause (ii), the Secretary may establish exceptions that permit a PDP sponsor offering a prescription drug plan to exclude from its formulary a particular covered part D drug in a category or class that is otherwise required to be included in the formulary under subclause (I) (or to otherwise limit access to such a drug, including through prior authorization or utilization management).</text></subclause></clause><clause commented="no" display-inline="no-display-inline" id="id431295c35da84765b5d4aceab833e612"><enum>(ii)</enum><header display-inline="yes-display-inline">Implementation</header><text display-inline="yes-display-inline">The Secretary shall establish any exceptions under clause (i)(II) through the promulgation of a regulation which includes a public notice and comment period.</text></clause><clause commented="no" display-inline="no-display-inline" id="idef1789868b5d4cbab60f766e2f6b470c"><enum>(iii)</enum><header display-inline="yes-display-inline">Requirement for certain categories and classes</header><text display-inline="yes-display-inline">The following categories and classes of drugs are described in this clause:</text><subclause commented="no" display-inline="no-display-inline" id="id878824deab514d22a723d17375c9d6a3"><enum>(I)</enum><text display-inline="yes-display-inline">Anticonvulsants.</text></subclause><subclause commented="no" display-inline="no-display-inline" id="id65b443c1262c429d8835b6a7217a5999"><enum>(II)</enum><text display-inline="yes-display-inline">Antidepressants.</text></subclause><subclause commented="no" display-inline="no-display-inline" id="ide1b502c1f4704e558861662026f4ece0"><enum>(III)</enum><text display-inline="yes-display-inline">Antineoplastics.</text></subclause><subclause commented="no" display-inline="no-display-inline" id="id96bd88c49c924d859464214791f9d48d"><enum>(IV)</enum><text display-inline="yes-display-inline">Antipsychotics.</text></subclause><subclause commented="no" display-inline="no-display-inline" id="id838fcf27793a4355a62f2de2fa081222"><enum>(V)</enum><text display-inline="yes-display-inline">Antiretrovirals.</text></subclause><subclause commented="no" display-inline="no-display-inline" id="id701eb1e387b54f278bc73a6c33dfd98a"><enum>(VI)</enum><text display-inline="yes-display-inline">Immunosuppressants for the treatment of transplant rejection.</text></subclause></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection commented="no" display-inline="no-display-inline" id="id81651625597144ffa163cb876f67ffff"><enum>(b)</enum><header display-inline="yes-display-inline">Effective date</header><text display-inline="yes-display-inline">The amendment made by subsection (a) shall apply to plan year 2015 and subsequent plan years.</text></subsection></section></legis-body></bill> 

